Ackermans & Van Haaren NVACKB

Capital at risk.

Calendar
event
Ex dividend date
30 May 2024
event_available
Last Dividend Payment
01 Jan 1970
About Ackermans & Van Haaren NV
Ticker
info
ACKB
Trading on
info
BR
ISIN
info
BE0003764785
Industry
info
Engineering & Construction
Sector
info
Industrials
CEO
info
Piet Dejonghe
Headquarters
info
Begijnenvest 113, Antwerp, undefined, Belgium, 2000
Employees
info
24,384
Website
info
avh.be
Ackermans & Van Haaren NV engages in marine engineering and contracting, private banking, real estate and senior care, and energy and resources businesses worldwide. The Marine Engineering & Contracting segment engages in the marine construction activities, including dredging and civil works on water, as well as offshore activities in the areas of renewable energy, oil and gas, soil and sludge remediation, and aggregate and mineral extraction; real estate development, multitechnics, and construction and renovation activities; and development of port projects and related industrial zones, as well as offshore wind farms. The Private Banking segment offers discretionary asset management services for private clients; specialized advisory banking services for entrepreneurs and liberal professionals; and financing and financial leasing of cars, equipment, charging stations, and bicycles. The Real Estate & Senior Care segment develops mixed real estate projects, including redevelopment of iconic buildings and new constructions; and develops residential, and retail and office properties. The Energy & Resources segment produces crude palm oil and bananas; offers hybrid palm oil seeds; and manufactures cement. The AvH & Growth Capital provides engineering and solutions in production process automation; validation and compliance services; production and sale of compact biogas installations; manufactures and supplies specialty chemicals; provides broadcast and media solutions; online and printed news; logistics for rail and road transport, and intermodal transport, and warehousing services; develops new vaccines, and crop and food protection products; and deals and leases commercial vehicles, and distribution of aftermarket products. This segment also develops medical devices; medicines for the treatment of cancer and genetic diseases; and supplies medical equipment and consumables to hospitals through online. The company was founded in 1876 and is based in Antwerp, Belgium.
Metrics
BasicAdvanced
Market cap
info
€6.64B
P/E ratio
info
14.46
EPS
info
€14.05
Dividend Yield
info
1.68%
Beta
info
0.69
Forward P/E ratio
info
14.18
EBIDTA
info
€1.15B
Ex dividend date
info
2024-05-30
Price & volume
Market cap
info
€6.64B
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
€3.80
Dividend yield
info
1.68%
Forward dividend per share
info
€3.40
Forward dividend yield
info
1.68%
Payout ratio
info
24.20%
Valuation
P/E ratio
info
14.46
Forward P/E
info
14.18
PEG ratio
info
0
Trailing P/E
info
14.46
Price to sales
info
1.1
Price to book
info
1.25
Earnings
EPS
info
€14.05
EPS estimate (current quarter)
info
€0.00
EPS estimate (next quarter)
info
€0.00
EBITDA
info
€1.15B
Revenues (TTM)
info
€6.04B
Revenues per share (TTM)
info
€184.89
Technicals
Beta
info
0.69
52-week High
info
€203.20
52-week Low
info
€151.04
50-day moving average
info
€193.13
200-day moving average
info
€183.65
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
9.14%
ROA (TTM)
info
2.27%
Profit margin
info
7.61%
Gross profit margin
info
€2.24B
Operating margin
info
12.96%
Growth
Quarterly earnings growth (YoY)
info
13.80%
Quarterly revenue growth (YoY)
info
13.00%
Share stats
Outstanding Shares
info
32.7M
Float
info
21.6M
Insiders %
info
33.34%
Institutions %
info
12.70%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-
-
-
Q4 • 13Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
€2.79B
€228M
8.18%
Q4 • 23
€2.89B
€200M
6.95%
Q2 • 24
3.29%
12.29%
15.08%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
€19.7B
€13.2B
66.96%
Q2 • 24
€20.3B
€13.5B
66.41%
Q4 • 24
2.98%
2.13%
0.82%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
€414M
-
€-186M
€214M
Q4 • 23
€588M
-
€-256M
€406M
Q2 • 24
42.12%
-
37.36%
89.81%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Ackermans & Van Haaren NV share?
Collapse

Ackermans & Van Haaren NV shares are currently traded for undefined per share.

How many shares does Ackermans & Van Haaren NV have?
Collapse

Ackermans & Van Haaren NV currently has 32.7M shares.

Does Ackermans & Van Haaren NV pay dividends?
Collapse

Yes, Ackermans & Van Haaren NV does pay dividends.

What is Ackermans & Van Haaren NV 52 week high?
Collapse

Ackermans & Van Haaren NV 52 week high is €203.20.

What is Ackermans & Van Haaren NV 52 week low?
Collapse

Ackermans & Van Haaren NV 52 week low is €151.04.

What is the 200-day moving average of Ackermans & Van Haaren NV?
Collapse

Ackermans & Van Haaren NV 200-day moving average is €183.65.

Who is Ackermans & Van Haaren NV CEO?
Collapse

The CEO of Ackermans & Van Haaren NV is Piet Dejonghe.

How many employees Ackermans & Van Haaren NV has?
Collapse

Ackermans & Van Haaren NV has 24,384 employees.

What is the market cap of Ackermans & Van Haaren NV?
Collapse

The market cap of Ackermans & Van Haaren NV is €6.64B.

What is the P/E of Ackermans & Van Haaren NV?
Collapse

The current P/E of Ackermans & Van Haaren NV is 14.46.

What is the EPS of Ackermans & Van Haaren NV?
Collapse

The EPS of Ackermans & Van Haaren NV is €14.05.

What is the PEG Ratio of Ackermans & Van Haaren NV?
Collapse

The PEG Ratio of Ackermans & Van Haaren NV is 0.